Omada Health (OMDA) Research & Development (2024 - 2026)

Omada Health (OMDA) has 3 years of Research & Development data on file, last reported at $12.7 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 37.05% year-over-year to $12.7 million; the trailing twelve-month figure through Mar 2026 stood at $33.2 million (down 29.64% YoY), and the FY2025 full-year result was $40.7 million, up 13.25% from the prior year.
• Research & Development grew to $12.7 million in Q1 2026, from -$24.7 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $22.9 million in Q3 2025 to a low of -$24.7 million in Q4 2025.
• A 3-year average of $10.1 million and a median of $10.9 million in 2024 frame the typical range for Research & Development.
• Peak annual rise in Research & Development reached 159.24% in 2025, while the deepest fall reached 369.29% in 2025.
• Tracing OMDA's Research & Development over 3 years: stood at $9.2 million in 2024, then plunged by 369.29% to -$24.7 million in 2025, then soared by 151.31% to $12.7 million in 2026.
• Business Quant data shows OMDA's Research & Development at $12.7 million in Q1 2026, -$24.7 million in Q4 2025, and $22.9 million in Q3 2025.